Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 1, 1978American Journal of Veterinary Research

Administration of Se-E resulted in decreased incidence and severity of cardiomyopathy and decreased cumulative mortality during a 10-week experiment.

View Full Paper
Ask AI
Bookmark
Share

Why the study?

Does Selenium-Vitamin E reduce adriamycin-induced cardiomyopathy and mortality in rabbits?

Population

Weanling rabbits chronically treated with adriamycin

Comparison

Selenium-vitamin E (Se-E) vs Adriamycin alone (implied)

Design

Preclinical

Follow-up

10 weeks

Authors

JVJohn F. Van VleetLGLinda A. GreenwoodVFVictor J. Ferrans

Discussion

Loading...

Member takes

Overview

Rabbit data support Se-E trials for anthracycline cardiotoxicity; leaves open human efficacy and safety.

Structured PICO

Does Selenium-Vitamin E reduce adriamycin-induced cardiomyopathy and mortality in rabbits?

P
Population
Weanling rabbits chronically treated with adriamycin
I
Intervention
Selenium-vitamin E (Se-E)
C
Comparator
Adriamycin alone (implied)
O
Outcome
Incidence and severity of cardiomyopathy and cumulative mortalitysurrogate

Selenium-vitamin E partially protects against adriamycin-induced cardiomyopathy and mortality in a rabbit model.

Cite This Study

Vleet et al. (1978) studied this question.

synapsesocial.com/papers/6a72d24faa61a8b0231ae359https://doi.org/10.2460/ajvr.1978.39.06.997
View Full Paper
Ask AI
Bookmark
Share